Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Orthofix Medical (OFIX) over the last 16 years, with Q3 2025 value amounting to $12.4 million.

  • Orthofix Medical's Cash from Operations rose 626.34% to $12.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.4 million, marking a year-over-year increase of 73400.95%. This contributed to the annual value of $25.8 million for FY2024, which is 15636.79% up from last year.
  • Latest data reveals that Orthofix Medical reported Cash from Operations of $12.4 million as of Q3 2025, which was up 626.34% from $11.6 million recorded in Q2 2025.
  • Over the past 5 years, Orthofix Medical's Cash from Operations peaked at $23.7 million during Q4 2024, and registered a low of -$34.0 million during Q1 2023.
  • Its 5-year average for Cash from Operations is -$388210.5, with a median of $477000.0 in 2023.
  • In the last 5 years, Orthofix Medical's Cash from Operations plummeted by 41581.32% in 2022 and then surged by 234675.05% in 2024.
  • Over the past 5 years, Orthofix Medical's Cash from Operations (Quarter) stood at $11.8 million in 2021, then plummeted by 80.07% to $2.3 million in 2022, then tumbled by 385.09% to -$6.7 million in 2023, then surged by 454.5% to $23.7 million in 2024, then tumbled by 47.74% to $12.4 million in 2025.
  • Its last three reported values are $12.4 million in Q3 2025, $11.6 million for Q2 2025, and -$18.4 million during Q1 2025.